Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125248484 | 12524848 | 4 | F | 20160601 | 20160712 | 20160704 | 20160725 | EXP | PHJP2016JP018451 | NOVARTIS | 46.11 | YR | M | Y | 57.00000 | KG | 20160725 | PH | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125248484 | 12524848 | 1 | PS | ZOMETA | ZOLEDRONIC ACID | 1 | Intravenous drip | 4 MG/5ML, UNK | N | 21223 | SOLUTION FOR INFUSION | ||||||||
125248484 | 12524848 | 2 | SS | RANMARK | DENOSUMAB | 1 | Unknown | 120 MG, UNK | N | 0 | 120 | MG | INJECTION | ||||||
125248484 | 12524848 | 3 | SS | DECADRON | DEXAMETHASONE | 1 | Oral | 4 MG, UNK | N | U | 0 | 4 | MG | TABLET | |||||
125248484 | 12524848 | 4 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | U | 0 | |||||||||
125248484 | 12524848 | 5 | C | FENTOS | FENTANYL | 1 | Unknown | 10 MG, UNK | 0 | 10 | MG | TAPE (INCLUDING POULTICE) | |||||||
125248484 | 12524848 | 6 | C | DAIKENCHUTO | HERBALS | 1 | Oral | 7.5 G, UNK | 0 | 7.5 | G | POWDER (EXCEPT [DPO]) | |||||||
125248484 | 12524848 | 7 | C | TS-1 | GIMERACILOTERACILTEGAFUR | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | TABLET | |||||||
125248484 | 12524848 | 8 | C | CELECOX | CELECOXIB | 1 | Oral | 100 MG, BID | 0 | 100 | MG | TABLET | BID | ||||||
125248484 | 12524848 | 9 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | Oral | 0.5 UG, UNK | 0 | .5 | UG | CAPSULE | |||||||
125248484 | 12524848 | 10 | C | POTASSIUM ASPARTATE | POTASSIUM ASPARTATE | 1 | Oral | 800 MG, UNK | 0 | 800 | MG | POWDER (EXCEPT [DPO]) | |||||||
125248484 | 12524848 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | |||||||
125248484 | 12524848 | 12 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125248484 | 12524848 | 1 | Metastases to bone |
125248484 | 12524848 | 2 | Metastases to bone |
125248484 | 12524848 | 3 | General physical health deterioration |
125248484 | 12524848 | 4 | Rectal cancer recurrent |
125248484 | 12524848 | 5 | Pain |
125248484 | 12524848 | 6 | Ileus |
125248484 | 12524848 | 7 | Rectal cancer |
125248484 | 12524848 | 8 | Product used for unknown indication |
125248484 | 12524848 | 9 | Product used for unknown indication |
125248484 | 12524848 | 10 | Product used for unknown indication |
125248484 | 12524848 | 11 | Product used for unknown indication |
125248484 | 12524848 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125248484 | 12524848 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125248484 | 12524848 | Osteonecrosis | |
125248484 | 12524848 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125248484 | 12524848 | 1 | 20150806 | 20160105 | 0 | |
125248484 | 12524848 | 2 | 20160301 | 20160531 | 0 | |
125248484 | 12524848 | 3 | 20130820 | 20160128 | 0 | |
125248484 | 12524848 | 5 | 20131017 | 0 | ||
125248484 | 12524848 | 6 | 20120120 | 0 | ||
125248484 | 12524848 | 7 | 20160510 | 0 | ||
125248484 | 12524848 | 8 | 20160113 | 0 | ||
125248484 | 12524848 | 9 | 20160329 | 0 | ||
125248484 | 12524848 | 10 | 20160329 | 0 | ||
125248484 | 12524848 | 11 | 20160510 | 0 | ||
125248484 | 12524848 | 12 | 201201 | 0 |